Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-018634

President and CEO acquired 15,450 shares (option exercise)

  • President and CEO gave up 5,343 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-30 Exercise or conversion : show line 1 in the form +15,450 $0.94 $14,470 180,838 D
2020-09-30 Shares withheld for taxes : show line 2 in the form −5,343 $0.94 $5,004 175,495 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −15,450 108,150 D
Loading xslF345X03/ownership.xml…